Primary Peritoneal Carcinoma Terminated Phase 1 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01202890Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTreatment